| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.6 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |